Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 0.00 (-0.79%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Interest Expenses (2023)

Updated

Pasithea Therapeutics' Interest Expenses was -$117,191 in Q2 2023.

Analysis

Pasithea Therapeutics (KTTA) Interest Expenses (2023) Analysis & Trends

For FY2022, Interest Expenses at Pasithea Therapeutics came in at $102.00, down 79.9% from FY2021.

  • In earlier years, Interest Expenses was $508.00 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -117,191.00
Mar 31, 2023 6,388.00
API Access

Pasithea Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=KTTA&period=max&api_key=YOUR_API_KEY